Trial Outcomes & Findings for Equity Using Interventions for Pain and Depression - Pilot Study (NCT NCT05695209)
NCT ID: NCT05695209
Last Updated: 2025-06-11
Results Overview
The pain interference score averages seven ratings, 0 (does not interfere) to 10 (interferes completely), of interference with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.
COMPLETED
NA
30 participants
3 months
2025-06-11
Participant Flow
Potentially eligible participants (primary care patients within an academic, safety-net healthcare system) were identified through electronic medical records and sent a letter and brochure describing the study. A study team member followed up with a phone call to assess interest and, if interested, screen for eligibility.
Participant milestones
| Measure |
Coaching and Decision Aid
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
Wait-list control group
|
|---|---|---|
|
3-months
STARTED
|
16
|
14
|
|
3-months
COMPLETED
|
14
|
13
|
|
3-months
NOT COMPLETED
|
2
|
1
|
|
6-months
STARTED
|
14
|
14
|
|
6-months
COMPLETED
|
13
|
13
|
|
6-months
NOT COMPLETED
|
1
|
1
|
Reasons for withdrawal
| Measure |
Coaching and Decision Aid
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
Wait-list control group
|
|---|---|---|
|
3-months
Withdrawal by Subject
|
2
|
0
|
|
3-months
Unable to contact for 3-month data collection
|
0
|
1
|
|
6-months
Lost to Follow-up
|
1
|
1
|
Baseline Characteristics
Equity Using Interventions for Pain and Depression - Pilot Study
Baseline characteristics by cohort
| Measure |
Coaching and Decision Aid
n=16 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=14 Participants
Wait-list control group
|
Total
n=30 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
59.9 years
STANDARD_DEVIATION 14.3 • n=5 Participants
|
61.3 years
STANDARD_DEVIATION 13.4 • n=7 Participants
|
60.6 years
STANDARD_DEVIATION 13.6 • n=5 Participants
|
|
Sex/Gender, Customized
Male
|
4 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Sex/Gender, Customized
Female
|
12 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
21 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
16 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
30 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
14 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
28 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
16 participants
n=5 Participants
|
14 participants
n=7 Participants
|
30 participants
n=5 Participants
|
|
Highest level of education completed
Some Secondary School or High School Education
|
5 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
|
Highest level of education completed
High School (or Secondary School) Degree Complete
|
7 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
|
Highest level of education completed
Associate's or Technical Degree Complete
|
4 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Highest level of education completed
College/Baccalaureate/Doctoral or Postgraduate Education
|
0 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Current relationship status
Divorced/Separated
|
3 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Current relationship status
Married/Domestic Partner
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Current relationship status
Never Married
|
8 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Current relationship status
Widowed
|
2 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
|
Current relationship status
Other
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Employment status
Full-time employment
|
2 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
|
Employment status
Not employed
|
13 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Employment status
Part-time employment
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Household income
Comfortable
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Household income
Just enough to make ends meet
|
10 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
18 Participants
n=5 Participants
|
|
Household income
Not enough to make ends meet
|
4 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Pain duration
|
140.6 months
STANDARD_DEVIATION 117.2 • n=5 Participants
|
146.2 months
STANDARD_DEVIATION 165.9 • n=7 Participants
|
143.2 months
STANDARD_DEVIATION 139.5 • n=5 Participants
|
PRIMARY outcome
Timeframe: 3 monthsThe pain interference score averages seven ratings, 0 (does not interfere) to 10 (interferes completely), of interference with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.
Outcome measures
| Measure |
Coaching and Decision Aid
n=14 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Brief Pain Inventory (BPI) Interference Scale at 3 Months
|
-1.02 units on a scale
Standard Deviation 1.87
|
-0.30 units on a scale
Standard Deviation 2.24
|
PRIMARY outcome
Timeframe: 6 monthsThe pain interference score averages seven ratings, 0 (does not interfere) to 10 (interferes completely), of interference with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=12 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Brief Pain Inventory (BPI) Interference Scale at 6 Months
|
-1.75 units on a scale
Standard Deviation 2.28
|
-1.14 units on a scale
Standard Deviation 1.51
|
SECONDARY outcome
Timeframe: 3 monthsThe PHQ-8 is a widely-used, validated 8-item measure of depression severity. The PHQ-8 is scored by assigning a value of 0 (not at all) to 3 (nearly every day) to each of the 8 items, with a total score ranging from 0 to 24. Higher scores indicate worse depression severity.
Outcome measures
| Measure |
Coaching and Decision Aid
n=14 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Patient Health Questionnaire (PHQ)-8 at 3 Months
|
-2.36 units on a scale
Standard Deviation 5.57
|
-0.77 units on a scale
Standard Deviation 4.44
|
SECONDARY outcome
Timeframe: 6 monthsThe PHQ-8 is a widely-used, validated 8-item measure of depression severity. The PHQ-8 is scored by assigning a value of 0 (not at all) to 3 (nearly every day) to each of the 8 items, with a total score ranging from 0 to 24. Higher scores indicate worse depression severity.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Patient Health Questionnaire (PHQ)-8 at 6 Months
|
-2.15 units on a scale
Standard Deviation 4.18
|
-0.46 units on a scale
Standard Deviation 4.75
|
SECONDARY outcome
Timeframe: 3 monthsAnxiety will be measured with the 7 item Generalized Anxiety Disorder Scale (GAD-7). The GAD-7 is scored by assigning a value of 0 to 3 to each of the seven items, with a total score ranging from 0 to 21. The total score indicates the severity of anxiety symptoms (higher scores indicating a worse outcome).
Outcome measures
| Measure |
Coaching and Decision Aid
n=14 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Generalized Anxiety Disorder Scale (GAD-7) at 3 Months
|
-3.29 units on a scale
Standard Deviation 5.01
|
-0.08 units on a scale
Standard Deviation 6.30
|
SECONDARY outcome
Timeframe: 6 monthsAnxiety will be measured with the 7 item Generalized Anxiety Disorder Scale (GAD-7). The GAD-7 is scored by assigning a value of 0 to 3 to each of the seven items, with a total score ranging from 0 to 21. The total score indicates the severity of anxiety symptoms (higher scores indicating a worse outcome).
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Generalized Anxiety Disorder Scale (GAD-7) at 6 Months
|
-3.23 units on a scale
Standard Deviation 3.75
|
-0.23 units on a scale
Standard Deviation 4.40
|
SECONDARY outcome
Timeframe: 3 monthsThe Pain Catastrophizing Scale is a 13-item scale that assesses catastrophizing-a cognitive-emotional factor that predicts poor treatment response. The scale uses a 5-point Likert scale ranging from 0 (not at all) to 4 (all the time) for each item with a total score ranging from 0 to 52. Higher scores indicate a worse outcome.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Pain Catastrophizing Scale at 3 Months
|
-4.31 units on a scale
Standard Deviation 11.26
|
3.54 units on a scale
Standard Deviation 8.78
|
SECONDARY outcome
Timeframe: 6 monthsThe Pain Catastrophizing Scale is a 13-item scale that assesses catastrophizing-a cognitive-emotional factor that predicts poor treatment response. The scale uses a 5-point Likert scale ranging from 0 (not at all) to 4 (all the time) for each item with a total score ranging from 0 to 52. Higher scores indicate a worse outcome.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Pain Catastrophizing Scale at 6 Months
|
-5.00 units on a scale
Standard Deviation 13.39
|
-2.12 units on a scale
Standard Deviation 12.01
|
SECONDARY outcome
Timeframe: 3 monthsPatient engagement will be measured with the 12-item Altarum Consumer Engagement (ACE) Measure, which has 3 subscales: 1) commitment to manage one's health, 2) informed choice, and 3) confidence to participate in treatment decisions. Each item is assessed on a 5-point Likert scale ranging from 0 (strongly disagree) to 4 (strongly agree) with a total score ranging from 0 to 48. Higher scores indicate greater engagement.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Altarum Consumer Engagement (ACE) Measure at 3 Months
|
2.64 units on a scale
Standard Deviation 8.96
|
-2.04 units on a scale
Standard Deviation 9.16
|
SECONDARY outcome
Timeframe: 6 monthsPatient engagement will be measured with the 12-item Altarum Consumer Engagement (ACE) Measure, which has 3 subscales: 1) commitment to manage one's health, 2) informed choice, and 3) confidence to participate in treatment decisions. Each item is assessed on a 5-point Likert scale ranging from 0 (strongly disagree) to 4 (strongly agree) with a total score ranging from 0 to 48. Higher scores indicate greater engagement.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Altarum Consumer Engagement (ACE) Measure at 6 Months
|
4.29 units on a scale
Standard Deviation 7.16
|
-0.24 units on a scale
Standard Deviation 10.93
|
SECONDARY outcome
Timeframe: 3 monthsThe NSCAP asks about 9 nonpharmacological treatment (NPT) modalities and assesses details of use such as frequency, location/source of service, and patients' judgments of effectiveness. Space is also provided for other NPTs that are used but not listed. The number of modalities for which patients answer "yes" will be summed for analyses.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Use of Nonpharmacological and Self-Care Approaches (NSCAP) at 3 Months
|
0.23 counts of NPTs
Standard Deviation 1.96
|
-0.46 counts of NPTs
Standard Deviation 1.61
|
SECONDARY outcome
Timeframe: 6 monthsThe NSCAP asks about 9 nonpharmacological treatment (NPT) modalities and assesses details of use such as frequency, location/source of service, and patients' judgments of effectiveness. Space is also provided for other NPTs that are used but not listed. The number of modalities for which patients answer "yes" will be summed for analyses.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Use of Nonpharmacological and Self-Care Approaches (NSCAP) at 6 Months
|
0.38 counts of NPTs
Standard Deviation 1.50
|
0.54 counts of NPTs
Standard Deviation 1.94
|
SECONDARY outcome
Timeframe: 3 monthsCommunication self-efficacy will be measured with this 5-item scale that measures patients' self-efficacy in obtaining medical information and getting their most important health concern discussed in a clinic visit. Higher scores indicate greater communication self-efficacy. The scale uses ratings from 0 (not at all confident) to 10 (extremely confident) for each item with a total score ranging from 0 to 50.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-5) at 3 Months
|
0.08 score on a scale
Standard Deviation 5.45
|
2.08 score on a scale
Standard Deviation 10.90
|
SECONDARY outcome
Timeframe: 6 monthsCommunication self-efficacy will be measured with this 5-item scale that measures patients' self-efficacy in obtaining medical information and getting their most important health concern discussed in a clinic visit. Higher scores indicate greater communication self-efficacy. The scale uses ratings from 0 (not at all confident) to 10 (extremely confident) for each item with a total score ranging from 0 to 50.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-5) at 6 Months
|
1.46 units on a scale
Standard Deviation 4.41
|
0.15 units on a scale
Standard Deviation 8.71
|
SECONDARY outcome
Timeframe: 3 monthsShared decision making will be measured with CollaboRATE, a 3-item measure assessing provider effort from the patient's perspective to engage in shared-decision making during a recent appointment. The CollaboRATE scale uses a 5-point Likert scale, ranging from "No effort was made (0)" to "Every effort was made (4)" for each item with a total score ranging from 0 to 12. Higher scores indicate higher provider effort from the patient's perspective to engage in shared-decision making.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline CollaboRATE at 3 Months
|
0.26 units on a scale
Standard Deviation 0.47
|
-0.13 units on a scale
Standard Deviation 0.91
|
SECONDARY outcome
Timeframe: 6 monthsShared decision making will be measured with CollaboRATE, a 3-item measure assessing provider effort from the patient's perspective to engage in shared-decision making during a recent appointment. The CollaboRATE scale uses a 5-point Likert scale, ranging from "No effort was made (0)" to "Every effort was made (4)" or each item with a total score ranging from 0 to 12. Higher scores indicate higher provider effort from the patient's perspective to engage in shared-decision making.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline CollaboRATE at 6 Months
|
0.26 units on a scale
Standard Deviation 0.71
|
-0.05 units on a scale
Standard Deviation 0.49
|
SECONDARY outcome
Timeframe: 3 monthsThe Working Alliance Inventory (WAI) Client Short Form assesses patient-provider agreement on treatment goals, collaboration to achieve these goals, and degree of emotional bond (liking and trust) between patients and providers. The scale uses ratings from 1 (Never) to 7 (Always) for each item with a total score ranging from 12 to 84. Higher scores indicate greater alliance between patient and provider.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Working Alliance Inventory (WAI) Client Short Form at 3 Months
|
3.67 units on a scale
Standard Deviation 13.34
|
-5.54 units on a scale
Standard Deviation 13.08
|
SECONDARY outcome
Timeframe: 6 monthsThe Working Alliance Inventory (WAI) Client Short Form assesses patient-provider agreement on treatment goals, collaboration to achieve these goals, and degree of emotional bond (liking and trust) between patients and providers. The scale uses ratings from 1 (Never) to 7 (Always) or each item with a total score ranging from 12 to 84. Higher scores indicate greater alliance between patient and provider.
Outcome measures
| Measure |
Coaching and Decision Aid
n=13 Participants
Individual coaching sessions and Decision Aid
Coaching and Decision Aid: Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
|
Control
n=13 Participants
Wait-list control group
|
|---|---|---|
|
Change From Baseline Working Alliance Inventory (WAI) Client Short Form at 6 Months
|
5.69 units on a scale
Standard Deviation 9.78
|
-2.38 units on a scale
Standard Deviation 8.05
|
Adverse Events
Coaching and Decision Aid
Control: Received Decision Aid
Control: Usual Care Without Decision Aid
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place